These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26386786)

  • 21. Effect of 0.5 mg versus 1 mg varenicline for smoking cessation: a randomized controlled trial.
    Fouz-Rosón N; Montemayor-Rubio T; Almadana-Pacheco V; Montserrat-García S; Gómez-Bastero AP; Romero-Muñoz C; Polo-Padillo J
    Addiction; 2017 Sep; 112(9):1610-1619. PubMed ID: 28449281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Intensive Personalized "5As+5Rs" Intervention on Smoking Cessation in Hospitalized Acute Coronary Syndrome Patients Not Ready to Quit Immediately: A Randomized Controlled Trial.
    Luo JG; Han L; Chen LW; Gao Y; Ding XJ; Li Y; Ja Y; Yang M; Ma CS
    Nicotine Tob Res; 2018 Apr; 20(5):596-605. PubMed ID: 28637193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial.
    Gray KM; Rubinstein ML; Prochaska JJ; DuBrava SJ; Holstein AR; Samuels L; McRae TD
    Lancet Child Adolesc Health; 2020 Nov; 4(11):837-845. PubMed ID: 32979939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining intensive practice nurse counselling or brief general practitioner advice with varenicline for smoking cessation in primary care: study protocol of a pragmatic randomized controlled trial.
    van Rossem C; Spigt M; Smit ES; Viechtbauer W; Mijnheer KK; van Schayck CP; Kotz D
    Contemp Clin Trials; 2015 Mar; 41():298-312. PubMed ID: 25657051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
    Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C
    Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial.
    Tonstad S; Holme I; Tønnesen P
    Nicotine Tob Res; 2011 Jan; 13(1):1-6. PubMed ID: 21041839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of treatment success in smoking cessation with varenicline combined with nicotine replacement therapy v. varenicline alone.
    Noor F; Koegelenberg CFN; Esterhuizen TM; Irusen EM
    S Afr Med J; 2017 Dec; 108(1):45-49. PubMed ID: 29262978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varenicline for Smoking Cessation in Light Smokers.
    Ebbert JO; Croghan IT; Hurt RT; Schroeder DR; Hays JT
    Nicotine Tob Res; 2016 Oct; 18(10):2031-5. PubMed ID: 27117285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.
    Thomas D; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn CP; Hall W; Paul C; Zwar N; Ferguson SG; Boland VC; Richmond R; Doran CM; Shakeshaft A; Mattick RP; Courtney RJ
    Addiction; 2019 May; 114(5):923-933. PubMed ID: 30589984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
    Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
    Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experience of varenicline for smoking cessation.
    Jung JW; Jeon EJ; Kim JG; Yang SY; Choi JC; Shin JW; Park IW; Choi BW; Kim DK; Kim JY
    Clin Respir J; 2010 Oct; 4(4):215-21. PubMed ID: 20887344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.
    Fagerström K; Russ C; Yu CR; Yunis C; Foulds J
    Nicotine Tob Res; 2012 Dec; 14(12):1467-73. PubMed ID: 22467778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline.
    Steinberg MB; Randall J; Greenhaus S; Schmelzer AC; Richardson DL; Carson JL
    Addict Behav; 2011 Dec; 36(12):1127-32. PubMed ID: 21835552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing the dose of varenicline in patients who do not respond to the standard dose.
    Jiménez-Ruiz CA; Barrios M; Peña S; Cicero A; Mayayo M; Cristóbal M; Perera L
    Mayo Clin Proc; 2013 Dec; 88(12):1443-5. PubMed ID: 24290118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial.
    Carson-Chahhoud KV; Smith BJ; Peters MJ; Brinn MP; Ameer F; Singh K; Fitridge R; Koblar SA; Jannes J; Veale AJ; Goldsworthy S; Hnin K; Esterman AJ
    PLoS One; 2020; 15(4):e0231095. PubMed ID: 32348306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions for smoking cessation in patients admitted with Acute Coronary Syndrome: a review.
    Chehab OM; Dakik HA
    Postgrad Med J; 2018 Feb; 94(1108):116-120. PubMed ID: 28942430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smoking Cessation in Patients With Acute Coronary Syndrome.
    Franck C; Filion KB; Eisenberg MJ
    Am J Cardiol; 2018 May; 121(9):1105-1111. PubMed ID: 29526275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial.
    Tulloch H; Pipe A; Els C; Aitken D; Clyde M; Corran B; Reid RD
    Contemp Clin Trials; 2014 Jul; 38(2):304-13. PubMed ID: 24861558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.